Skip to content

A study to develop a system of care that will provide timely and effective treatment for patients with STEMI ( ST Elevation Myocardial Infarction)

A Prospective controlled study of assertive and timely reperfusion of patients with ST â??Segment elevation myocardial infraction (STEMI) in Tamil Nadu.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/09/003002
Enrollment
500
Registered
2012-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Stemi

Interventions

Intervention1: â??An algorithm is developed and delivered using Information technology for rapid diagnosis and management of STEMIâ??: Tablet PC enabled with STEMI management software for rapid confir

Sponsors

STEMI India group
Lead Sponsor
Lotus Clinical Research Academy Pvt Ltd
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients above 20 years with typical symptoms and ECG confirmation of STEMI and patients above 35 years with atypical symptoms(epigastric pain, arm pain, diaphoresis, shortness of breath, syncope) and ECG confirmation of STEMI 2. ECG showing >= 1-mm ST-segment elevation in at least 2 anatomically contiguous limb leads (aVL to III, including -aVR), >= 1-mm ST-segment elevation in a precordial lead V4 through V6, >= 2-mm ST-segment elevation in V1 through V3 or a new left bundle branch block

Exclusion criteria

Exclusion criteria: 1. Patients with diagnosis other than STEMI

Design outcomes

Primary

MeasureTime frame
Following are sub-groups to be considered for analysis ï?§ Use of reperfusion ï?§ Use of timely reperfusion â?¢ Reduction in FMC to balloon/ needle time â?¢ Reduction in door to balloon time â?¤ 90 minutes and door to needle â?¤ 30 minutes â?¢ Composite of all-cause mortality, cardiac mortality, major bleeds (especially stroke), recurrent infarction/ischemia at 30 days, 6 months and one year Timepoint: â?¢Composite of all-cause mortality, cardiac mortality, major bleeds (especially stroke), recurrent infarction/ischemia at 30 days, 6 months and one year

Secondary

MeasureTime frame
â?¢ In-hospital complications, duration of hospitalization â?¢ Use of evidence- based therapies on admission, hospitalization and at discharge â?¢ Capacity outcomes to assess the ability to deal with STEMI in each of the participating units Timepoint: Composite of all-cause mortality, cardiac mortality, major bleeds (especially stroke), recurrent infarction/ischemia at 30 days, 6 months and one year

Countries

India

Contacts

Public ContactDr Thomas Alexander

Kovai Medical Center and Hospital,

tomalex41@gmail.com91-9791907685

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 10, 2026